Compare SOWG & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOWG | FBIO |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.9M | 80.4M |
| IPO Year | 2011 | 2011 |
| Metric | SOWG | FBIO |
|---|---|---|
| Price | $2.31 | $1.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.3K | ★ 236.1K |
| Earning Date | 11-13-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.40 |
| EPS | N/A | ★ 2.86 |
| Revenue | N/A | ★ $63,262,000.00 |
| Revenue This Year | N/A | $24.55 |
| Revenue Next Year | N/A | $43.73 |
| P/E Ratio | ★ N/A | $0.70 |
| Revenue Growth | N/A | ★ 9.69 |
| 52 Week Low | $0.10 | $1.83 |
| 52 Week High | $15.90 | $4.53 |
| Indicator | SOWG | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 46.28 | 38.56 |
| Support Level | $2.10 | $1.83 |
| Resistance Level | $2.62 | $2.17 |
| Average True Range (ATR) | 0.18 | 0.08 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 82.29 | 29.00 |
Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats. The company operates in one reportable segment, reflecting its capital-light business model under which it earns proceeds from the sale of freeze-dried candy products.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.